Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
AssigneeInnogenetics N.V.
InventorsGeert Maertens, Fons Bosman, Guy De Martynoff, Marie-Ange Buyse
Life of this patent
Estimating the term…
Loading patent…
AssigneeInnogenetics N.V.
InventorsGeert Maertens, Fons Bosman, Guy De Martynoff, Marie-Ange Buyse
Estimating the term…
The present invention relates to a method for purifying recombinant HCV single or specific oligomeric envelope proteins selected from the group consisting of E1 and/or E1/E2 characterized in that upon lysing the transformed host cells to isolate the recombinantly expressed protein a disulphide bond cleavage or reduction step is carried out with a disulphide bond cleavage agent. The present invention also relates to a composition isolated by such a method. The present invention also relates to the diagnostic and therapeutic application of these compositions. Furthermore, the invention relates to the use of HCV E1 protein and peptides for prognosing and monitoring the clinical effectiveness and/or clinical outcome of HCV treatment.
Kit for detecting antibodies to HCV comprising:
A method for detecting antibodies to HCV comprising:
Kit for detecting antibodies to HCV comprising an E1 protein of HCV and an E2 protein of HCV wherein at least one of said E1 protein and E2 protein has been purified to at least 80% pure;
A method for detecting antibodies to HCV comprising:
The method of claim 22 wherein said recombinant protein had been expressed in recombinant mammalian cells or recombinant yeast cells.
Dependencies are inferred from the claim text.